Yash Gupta
Dr. Yash Gupta is a biomedical scientist specializing in parasitology and infectious disease therapeutics. His research has significantly advanced the understanding of malaria pathogenesis and drug discovery. Dr. Gupta has identified novel antimalarial compounds such as Calxinin, a multistage inhibitor that disrupts Plasmodium falciparum calcium homeostasis, and has contributed to the development of HDAC and GAPDH-targeting therapeutics. His work integrates in silico modeling with in vitro and in vivo validation, resulting in high-impact publications and patents. With over 35 peer-reviewed articles and editorial roles in leading journals, Dr. Gupta’s contributions are internationally recognized. He has collaborated across institutions, including the Mayo Clinic and Penn State, and his discoveries are being translated into clinical applications through biotech partnerships.